Antipsychotics of Choice in Breast Cancer
Special consideration is required when prescribing antipsychotic drugs for patients with an existing diagnosis of breast cancer.
In general, first generation antipsychotics causes significant elevations in serum prolactin levels.
Antipsychotics that Increases Prolactin (45 to >100 ng/ml) and
Should be AVOIDED in Patients with Breast Cancer:
Antipsychotics that Increases Prolactin (20-50 ng/ml) and
Should be CAUTIONED in Patients with Breast Cancer:
Antipsychotics that Increases Minimal Prolactin and
Are PREFERRED in Patients with Breast Cancer:
Antipsychotic that may Lower Prolactin and
is PREFERRED in Patients with Breast Cancer:
Source: Am J Psychiatry 2014;171:616-621.
Please do post your questions or comments below.
Dr. Harvinder Singh, M.D. (Admin)
Enroll in our online course to have access to all important clinically relevant psychiatry topics in one place.